NCT06849011 (IMPACT-NEURO) is a clinical trial in Stroke Acute, sponsored by Yan Zhang.

Who is sponsoring NCT06849011?

NCT06849011 is sponsored by Yan Zhang.

What condition does NCT06849011 study?

NCT06849011 studies Stroke Acute, Encephalitis, Non-traumatic Brain Injury.

Is NCT06849011 still recruiting?

NCT06849011 is currently not yet recruiting. Last updated 27 February 2025.

Last reviewed 2025-02-27 · How we verify

NCT06849011: IMPACT-NEURO

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Inflammatory and Metabolic Prognostic Assessment in Critically Ill Neurological Patients

Not yet recruiting Last updated 27 February 2025

What this trial tests

trial in Stroke Acute in 1,185 participants. Not yet recruiting.

Timeline

1 March 2025

Primary endpoint
31 December 2026

31 March 2027

Quick facts

Lead sponsor	Yan Zhang
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	1,185
Start date	1 March 2025
Primary completion	31 December 2026
Estimated completion	31 March 2027
Sites	19 locations across China

Conditions studied

Stroke Acute — all drugs for Stroke Acute →
Encephalitis — all drugs for Encephalitis →
Non-traumatic Brain Injury — all drugs for Non-traumatic Brain Injury →

Sponsor

Yan Zhang — full company profile →

Who can join

Adults 18 to 80, any sex, with Stroke Acute or Encephalitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to develop and validate a prognostic prediction model for adverse outcomes in neurocritical patients receiving enteral nutrition based on key inflammatory and metabolic markers. This model will serve as a clinical tool to help physicians identify high-risk patients and guide individualized nutritional support strategies.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Stroke Acute

Currently open trials in the same condition.

NCT06975696 — Fusion Imaging in Endovascular Thrombectomy for Acute Ischemic Stroke · NA · recruiting
NCT07453277 — Blood-Based Molecular Clock Biomarkers Predict Acute Ischemic Stroke Onset: A Prospective Observational Study · active not recruiting
NCT07052045 — One-Stop manaGemEnT For A Swift Initiation of Endovascular Therapy · NA · recruiting
NCT07001852 — EnDOvascular Therapy for Late WiNdow IschEmic Stroke Patients Selected bY AutoMatic Plain ComputErized Tomography · NA · recruiting
NCT07319312 — Evaluating the Effect of Nurse-Led Stroke Transitional Care in Tanzania · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06849011 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yan Zhang
Last refreshed: 27 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06849011.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing